Background {#s1}
==========

Intussusception is the invagination of one segment of the intestine within a more distal segment [@pone.0068482-Bines1], [@pone.0068482-Bines2]. It is the most common cause of bowel obstruction in infants, occurring usually between 4 and 10 months of age [@pone.0068482-WHO1]. In most infants, the intussusception involves the ileum invaginating through the ileocecal valve into the cecum. As the bowel intussuscepts, it pulls along its blood supply. If the intussusception is not relieved, the vascular supply of the bowel may be compromised, resulting in intestinal ischemia and possibly perforation. Untreated intussusception may be fatal.

In 1999, an association was found between a tetravalent rhesus reassortant rotavirus vaccine (RotaShield) and intussusception in US infants prompting the manufacturer to withdraw the vaccine from the market [@pone.0068482-Murphy1], [@pone.0068482-Patel1]. Because of this association, the two rotavirus vaccines that are currently recommended by the World Health Organization \[RotaTeq (RV5), Merck & Co.; Rotarix (RV1), GSK Biologicals\] were evaluated in large safety trials which excluded a risk of intussusception similar to that found with RotaShield (1 excess case per 10,000 vaccinated infants) [@pone.0068482-Patel1], [@pone.0068482-WHO2]. However, postlicensure studies in some high and middle income settings have identified a low level risk of 1--2 excess cases of intussusception per 100,000 infants after both RV1 and RV5 [@pone.0068482-Patel2], [@pone.0068482-Buttery1]. These vaccines have now been introduced in some 45 countries worldwide, primarily in middle and high income countries, but broader introductions in low income countries of Africa and Asia are expected in next 3--5 years [@pone.0068482-Patel3].

The past experience with RotaShield and the identification of a lower level risk of intussusception after RV1 and RV5 highlights the importance of ongoing intussusception monitoring as these new vaccines are broadly adopted in other regions of the world. In 2002, the WHO published a comprehensive literature review of childhood intussusception globally between the years 1960--2002 [@pone.0068482-WHO1]. In anticipation of the global introduction of rotavirus vaccines, the objective of this literature review was to describe the epidemiology, diagnosis, and clinical manifestations of intussusception between the years 2002--2012. This review of the epidemiology of intussusception based on contemporary studies published in the last decade should serve as a valuable resource for implementing surveillance for intussusception to monitor the safety of these vaccines as they are broadly rolled out across the world.

Methods {#s2}
=======

Search strategy and selection criteria {#s2a}
--------------------------------------

We followed the PRISMA guidelines to identify all intussusception studies published between January 2002 (when the last review was conducted) and June 2012. We included all peer-reviewed articles and selected meeting abstracts. We searched PubMed MEDLINE and Google Scholar using the following keywords: "intussusception" or "intestinal invagination." We included all human studies of intussusception among children \<18 years of age published in English. Because we were interested in understanding the epidemiology of all intussusception events among children, full-text articles were not reviewed if they were case reports, animal studies, follow-up evaluation of chronic or recurrent intussusception, reports of intussusception events secondary to other conditions (e.g., vascular or congenital malformations, tumors), or reports of surgical or radiological management of intussusception. We also excluded those studies which did not include children \<1 year of age. We reviewed the reference lists of all included articles to identify additional sources of data, missing articles, or meeting abstracts. Where there were multiple sources of data from the same study population, we relied on the data from the most complete peer-reviewed publication.

Data Extraction and Management {#s2b}
------------------------------

Data from included studies were extracted onto a standardized table by JJ and MP. Reviewers were not blinded to study authors, affiliations, or journal name. Variables recorded from each article included, study locations (city & country), sample size, study period, age at diagnosis, month of presentation, diagnostic modality, treatment, death, and incidence.

Data Analysis {#s2c}
-------------

We grouped data according to seven geographic regions of the world: Africa, Asia, Central & South America, Eastern Mediterranean, Europe, North America, and Oceania. Because of heterogeneity in under 5 mortality rates (u5MR) in Asia, we grouped Asian countries into high u5MR and low/very low u5MR according to WHO classification [@pone.0068482-Okimoto1]. We present data on incidence of intussusception among children\<1 year of age. We averaged the annual rate when rates for multiple years were presented individually. Among countries reporting incidence of intussusception, we were also interested in determining incidence of intussusception by month during the first year of life. To determine a pooled estimate of intussusception incidence by month of age globally, we extrapolated the proportion of intussusception events by month of age from studies that either presented monthly incidence or number of cases to the remaining studies that only presented intussusception incidence among children \<1 year of age. While only 5 studies reported intussusception incidence by month of age, an additional 17 studies presented data on number of cases by month of age.

For studies reporting data on seasonality, we pooled data by geographic region on number of intussusception cases by calendar month. We also present pooled data on diagnostic modality, treatment, and prevalence of death by geographic region. For diagnosis and treatment, we excluded cases where this information was missing or unspecified.

All analyses were done with Microsoft EXCEL (Microsoft Corp, 2007).

Results {#s3}
=======

We reviewed 2757 abstracts to identify a total of 113 potential full-text articles and 1 meeting abstract, from which 82 studies met the inclusion criteria for our analysis ([Figure 1](#pone-0068482-g001){ref-type="fig"}; [Table 1](#pone-0068482-t001){ref-type="table"}) [@pone.0068482-Abantanga1]--[@pone.0068482-Awasthi1]. We excluded 31 articles due to non-English language (n = 8), duplicate data (n = 14), non-epidemiology study or review (6), included in previous review (2), or age \<1 excluded (1). Included studies reported a total of 44,454 intussusception events from North America (n = 16,425), Asia: low or very low mortality (n = 14,382), Europe (n = 6,280), Oceania (2,761), Africa (2,895), Eastern Mediterranean (n = 644), and Central & South America (n = 538), Asia: high mortality (n = 356). Of these 82 studies, 44 (60%) were hospital-based studies, whereas 38 (40%) represented national or regional data on intussusception hospitalizations.

![PRISMA flow diagram for the intussusception literature review.](pone.0068482.g001){#pone-0068482-g001}

10.1371/journal.pone.0068482.t001

###### List of all included studies.

![](pone.0068482.t001){#pone-0068482-t001-1}

  Country                          Study dates    National or Hospital based   No. of cases   Age, yrs                       Ref.
  ------------------------------- -------------- ---------------------------- -------------- ---------- ----------------------------------------------
  **Africa**                                                                     **2895**               
  Multiple^a^                       1993--2003          International              1069         \<1                  {Steele, 2012 \#92}
  Kenya                             2000--2003             Hospital                 36          \<6                  {Kuremu, 2004 \#55}
  Kenya                             1992--1999             Hospital                 29           NR                  {Muyembe, 2000 \#65}
  Ghana                             2004--2007             Hospital                 44          \<13                {Abantanga, 2008 \#1}
  Ghana                             2008--2009             Hospital                 77          \<5              {Enweronu-Laryea, 2012 \#35}
  Nigeria                           1980--1998             Hospital                 80          \<12                   {Ameh, 2002 \#3}
  Nigeria                           1988--1998             Hospital                 33          \<1                    {Ameh, 2002 \#4}
  Nigeria                           1989--1998             Hospital                 89          \<1                 {Archibong, 2001 \#5}
  Nigeria                           1995--2001             Hospital                174          \<7                   {Bode, 2008 \#12}
  Nigeria                           1996--2005             Hospital                 38          \<15                {Ogundoyin, 2009 \#69}
  Nigeria                           1998--2003             Hospital                 29          \<8                   {Edino, 2003 \#30}
  Nigeria                           1998--2007             Hospital                 87          \<8                  {Ekenze, 2010 \#31}
  Nigeria                           2008--2009             Hospital                 20          \<2                  {Ekenze, 2011 \#32}
  So. Africa                        1998--2003           9 Hospitals               423          \<14                  {Moore, 2010 \#63}
  So. Africa                        1996--2001             Hospital                106           NR                 {Wiersma, 2004 \#112}
  Tanzania                          2000--2004             Hospital                 28          \<10                {Carneiro, 2004 \#21}
  Tunisia                           1984--2003             National                533          \<5                 {Chouikha, 2009 \#27}
  **Asia--high u5MR**                                      **356**                                      
  Bangladesh                        2001--2006             Regional                 4           \<2                  {Zaman, 2009 \#109}
  India                             2000--2003             Hospital                 5           \<1                    {Bahl, 2009 \#7}
  India                             2001--2004             Hospital                 31          \<5                  {Bhowmick, 2009 \#8}
  India                             1991--2000             Hospital                137          \<5                   {Raman, 2003 \#75}
  India                                ----                Hospital                179           NR               {Ramachandran, 2008 \#74}
  **Asia--low & very low u5MR**                           **14382**                                     
  China                             2004--2009             Hospital                 56          \<14                 {Zhang, 2011 \#110}
  Hong Kong^b^                      1997--2003             National                531          \<5      {Hong Kong Intussusception Study, 2007 \#44}
  Hong Kong^b^                      1997--1999             National                190          \<5                  {Nelson, 2002 \#67}
  Japan                             2007--2008             National                2427         \<18                {Takeuchi, 2012 \#93}
  Japan                            1978 -- 2002            Hospital                 91          \<5                 {Nakagomi, 2006 \#66}
  So. Korea                         2000--2002             Regional                408          \<5                    {Jo, 2009 \#47}
  Malaysia                          2000--2003             Regional                 62          \<5                   {Giak, 2008 \#40}
  Singapore                         1997--2007             National                217          \<2                    {Tan, 2009 \#94}
  Taiwan                            1998--2007             National                8217         \<15                  {Chen, 2010 \#24}
  Thailand                          1992--2009             Hospital                737           NR                {Kruatrachue, 2011 \#54}
  Thailand                          2001--2006           5 hospitals               112          \<5                  {Khumjui, 2009 \#51}
  Thailand                          2000--2005             Hospital                 94          \<14              {Pruksananonda, 2007 \#73}
  Uzbekistan                        2004--2008             Regional                 67          \<2                  {Latipov, 2011 \#58}
  Vietnam                           2002--2003             Hospital                640          \<2                  {Justice, 2007 \#50}
  Vietnam                           2002--2004             Hospital                533          \<2                   {Bines, 2006 \#9}
  **Central & South Americas**                             **538**                                      
  Latin America                        n/a              International              222          \<2                     {Abate, \#111}
  Chile                             2000--2001             Regional                 95          \<2                  {O\'Ryan, 2003 \#71}
  Panama                            1998--2002             National                103          \<1               {Saez-Llorens, 2004 \#80}
  Trinidad                          2000--2007             Hospital                 65          \<3               {Tota-Maharaj, 2010 \#98}
  Venezuela                         1998--2001             Regional                 53          \<1               {Perez-Schael, 2003 \#72}
  **Eastern Mediterranean**                                **644**                                      
  Saudi Arabia                     1993 -- 2000            Hospital                 34          \<8                  {Al-Malki, 2005 \#2}
  Saudi Arabia                      1984--2000             Hospital                 37          \<3                 {Crankson, 2003 \#29}
  Israel                            1990--2004             Hospital                316          \<5                 {Greenberg, 2008 \#41}
  Israel                            2990--2002             Hospital                148          \<5                   {Eshed, 2003 \#36}
  Jordan                            1979--2003             Hospital                109          \<14                 {Saleem, 2008 \#81}
  **Europe**                                                                     **6280**               
  Austria                           1999--2006             Hospital                111          \<10                 {Saxena, 2007 \#85}
  Denmark                           1980--2001             National                1814         \<5                  {Fischer, 2004 \#39}
  Finland                           2001--2006             National                 53          \<13               {Lappalainen, 2012 \#57}
  Germany                           2006--2007             Regional                169          \<1                   {Wei, 2011 \#102}
  Germany                           2006--2007             National                1200         \<15                  {Jenke, 2011 \#46}
  Germany                           2005--2006             Regional                518          \<17                  {Kohl, 2010 \#53}
  Ireland                           1998--2010             Hospital                256          \<12                 {Tareen, 2011 \#96}
  Ireland                           1990--2000             Hospital                 24         \<2.5                  {Hilal, 2002 \#42}
  Russia                            1994--2005             Hospital                280          \<14                {Shapkina, 2006 \#86}
  Spain                            unspecified             Hospital                151          \<12                  {Rubi, 2002 \#78}
  Switzerland                       2003--2006             National                294          \<18                {Buettcher, 2007 \#17}
  Turkey                            1991--2007             Hospital                105          \<15                 {Sonmez, 2012 \#91}
  Turkey                            1993--2003             Hospital                179           NR                  {Yalcin, 2009 \#107}
  UK/Ireland                        2008--2009             National                261          \<1                   {Samad, 2012 \#83}
  UK/Ireland                       1997 -- 1998            Hospital                 32         \<1.5                {Willetts, 2001 \#104}
  England                           1993--1995             National                833          \<1                   {Gay, 1999 \#113}
  **North America**                                                             **16425**               
  Canada                            1993--2001             Regional                961          \<6                   {Somme, 2006 \#90}
  US                                2000--2009             National               10,836        \<1                   {Yen, 2012 \#108}
  US                                2001--2005           National^c^                22          \<1                    {Eng, 2012 \#34}
  US                                2002--2012             Hospital                405          \<7                   {Fike, 2012 \#38}
  US                                1996--2007             Regional                188          \<17              {Shekherdimian, 2011 \#87}
  US                                2002--2005        Military hospitals           293          \<5                  {Nylund, 2010 \#68}
  US                                2001--2006           3 Hospitals               183          \<1                  {Cortese, 2009 \#28}
  US                                1993--2004             National                3463         \<1                   {Tate, 2008 \#97}
  US                                2001--2004             Hospital                 26          \<14               {Burjonrappa, 2007 \#18}
  Mexico                            1999--2001             Regional                 48          \<1                {Velazquez, 2004 \#100}
  **Oceania**                                                                    **2761**               
  Australia                         2001--2009             Regional                197          \<2               {Lloyd-Johnsen, 2012 \#59}
  Australia                         2002--2004             Hospital                 51          \<2                   {Bines, 2006 \#9}
  Australia                         1994--2004             Regional                147          \<12                 {Blanch, 2007 \#11}
  Australia                         1993--2003             Regional                 23          \<18                 {Webby, 2006 \#101}
  Australia                         1994--2000             National                1794         \<1                  {Justice, 2006 \#49}
  New Zealand                       1998--2007             Hospital                189          \<14                {Kodikara, 2010 \#52}
  New Zealand                       1998--2003             National                277          \<3                   {Chen, 2005 \#25}
  New Zealand                       1987--1998             Regional                 83           NR                   {Reid, 2001 \#76}
  **Intercontinental/Global**                              **173**                                      
  India, Brazil, Egypt Kenya        2004--2006          International              173          \<10                 {Awasthi, 2009 \#6}

a: Botswana, Cote D\'Ivoire, Ghana, Kenya, Nigeria, South Africa, Tanzania, Zambia, Zimbabwe.

b: these 2 studies had overlapping study years in same location but were included because data on age and clinical treatment were split.

c: authors randomly sampled a cohort of 100,000 infants from a national insurance claims database.

Five reports presented incidence data by month of age, 17 studies presented data on number of cases by month of age and the incidence among children \<1 year of age, and 13 only reported aggregate intussusception incidence among children \<1 year of age. Among studies (n = 35) reporting incidence of intussusception among children \<1 year of age, the mean incidence was 74 per 100,000 infant years (range: 9--328) ([Table 2](#pone-0068482-t002){ref-type="table"}). While incidence in a majority (83%) of the studies was \<100 per 100,000, higher incidence was observed in some populations including: Australia (101), Hong Kong (108), Japan (185), Israel (219), Vietnam (302), and South Korea (328) ([Figure 2](#pone-0068482-g002){ref-type="fig"}). Incidence of intussusception was \<20 per 100,000 in some populations from Finland (20), India (18), Malaysia (18), and Bangladesh (9).

![Global map of intussusception incidence.\
In countries where local, regional, and national studies were conducted, we preferentially mapped the national rates. For countries with more than one national study, average rates of the studies were used for the map. If no national rates were available, regional and/or local rates were used for the map.](pone.0068482.g002){#pone-0068482-g002}

10.1371/journal.pone.0068482.t002

###### Intussusception incidence among children \<1 year of age by region.

![](pone.0068482.t002){#pone-0068482-t002-2}

  Continent                          Country          National/Regional/Hospital     Incidence per 100,000 \<1 Yr.   Rates stratified by month of age
  ----------------------------- ------------------ -------------------------------- ------------------------------- ----------------------------------
  **Africa**                       South Africa                National                          56^a^                              No
  **Asia (high u5MR)**              Bangladesh                 Regional                            9                                No
                                      India               Regional -- Delhi                       18                                No
                                     Tunisia                   National                           62                                No
  **Asia-low/very low u5MR**        Hong Kong                  National                           108                               No
                                      Japan                    National                         185^b^                              No
                                   South Korea       Regional (Jeonbuk Province)                328^c^                              No
                                     Malaysia                  National                           18                                No
                                    Singapore                  National                           51                                No
                                      Taiwan                   National                           77                                No
                                     Thailand                  National                           36                                No
                                    Uzbekistan           Regional -- Bukhara                      23                                No
                                     Vietnam                   Regional                           302                               No
  **Central & South America**      11 countries              11 countries                         51                                No
                                      Chile              Regional -- Santiago                     51                                No
                                      Panama                   National                           30                                No
                                    Venezuela            Regional -- Carabobo                     35                                No
  **Eastern Mediterranean**      Israel (Jewish)               Hospital                           219                               No
                                 Israel (Bedouin)              Hospital                           75                                No
  **Europe**                        Denmark^d^                 National                           66                               Yes
                                     Finland                   National                           20                                No
                                    Germany^d^        Regional -- Bavaria & NRW                   62                               Yes
                                     Germany                   National                           60                                No
                                     Germany             Regional -- Bavaria                      72                                No
                                   Switzerland                 National                           38                                No
                                    England^d^                 National                           66                               Yes
  **North America**                   US^d^                    National                           33                               Yes
                                        US                     National                           33                                No
                                        US                   3 hospitals                          49                                No
                                      US^d^                    National                           34                               Yes
  **Oceania**                       Australia           Regional -- Melbourne                     27                                No
                                                               Hospital                           71                                No
                                                    Regional -- Northern Territory                65                                No
                                                               National                           101                               No
                                   New Zealand                 National                           65                                No
  **ALL REGIONS (Average)**                                                                     **74**                            **No**

a: rate for \<2 year olds in the paper; we recalculated rate for \<1 year of age based on presented data.

b: midpoint of the range presented in the study.

c: rates presented for \<6 and 6--11 months in the paper; we recalculated rates for \<1 based on these data.

d: rates by age in months for the most recent surveillance years 1995--1999 were obtained from figure using Digitize-It; mean incidence for \<1 presented {Fischer, 2004 \#39}.

Five studies reported incidence of intussusception by month of age and 15 reported number of cases by month of age among children \<1 year of age. We extrapolated the proportion of intussusception incidence by month of age relative to the mean incidence among children \<1 year from the 5 studies to the 30 studies that only reported incidence among children \<1 year ([Figure 3](#pone-0068482-g003){ref-type="fig"}). The age distribution of intussusception incidence and number of cases were similar, with lowest incidence among children 0--2 months of age (13--37 per 100,000) and peak incidence among those 4--7 months of age (97--126 per 100,000).

![Incidence of intussusception by month of life during first year of life.\
Intussusception incidence or number of cases by month of life from 22 studies extrapolated to remaining 13 studies that only presented data on rates for infants \<1 year (as displayed in [Table 2](#pone-0068482-t002){ref-type="table"}).](pone.0068482.g003){#pone-0068482-g003}

Distribution of intussusception cases by calendar month of year was reported in 21 studies ([Figure 4](#pone-0068482-g004){ref-type="fig"}). No particular seasonal pattern in intussusception was seen globally or in any of the regions except North America ([Figure 5](#pone-0068482-g005){ref-type="fig"}); however, only 1 small study of 36 cases provided data on seasonality of intussusception in North America [@pone.0068482-Velazquez1].

![Seasonality of intussusception globally.](pone.0068482.g004){#pone-0068482-g004}

![Seasonality of intussusception, by WHO region.](pone.0068482.g005){#pone-0068482-g005}

Diagnosis of intussusception varied substantially by region. Diagnosis of intussusception was made by a radiographic modality (e.g., air-contrast enema, ultrasound, or computed tomography) in 95%--100% of the cases from all regions of the world except Africa where intussusception was diagnosed by clinical findings or surgery in 65% of the case; however, data on method of diagnosing intussusception were limited in countries from Eastern Mediterranean, Americas, and Oceania ([Figure 6](#pone-0068482-g006){ref-type="fig"}). Treatment of intussusception also differed by region ([Figure 7](#pone-0068482-g007){ref-type="fig"}), with higher prevalence of surgery in Central/South America (86%) and Africa (77%) compared to Eastern Mediterranean (29%), Oceania (29%), North America (28%), Europe (20%), and Asia (13%).

![Diagnosis of intussusception by WHO region.\
Studies where diagnosis was unspecified were not included. Data from Central and South America were from one prospective research study that might not reflect clinical practice under routine conditions.](pone.0068482.g006){#pone-0068482-g006}

![Treatment of intussusception by WHO region.\
Studies where treatment was unspecified were not included.](pone.0068482.g007){#pone-0068482-g007}

The proportion of children with intussusception who died after presenting to the hospital was substantially higher in Africa (9.4%; range  = 2--25) compared to Asia (0.2%; range  = 0--6), Central and South America (0.6%; range  = 0--1), Eastern Mediterranean (0.8%; range  = 0--5), Europe (0.1%; range  = 0--1), North America (0.4%; range  = 0--1); and Oceania (0%; range 0--0.1%) ([Table 3](#pone-0068482-t003){ref-type="table"}).

10.1371/journal.pone.0068482.t003

###### Case-fatality among children hospitalized with intussusception.

![](pone.0068482.t003){#pone-0068482-t003-3}

  Country                                                                                                               No. of IS cases   Deaths   
  -------------------------------------------------------------------------------------------------------------------- ----------------- --------- -----------
  **Total (Africa)**                                                                                                       **1961**       **185**   **9.4%**
  *Multi-country*: Botswana, Cote D\'Ivoire, Ghana, Kenya, Malawi, Nigeria, South Africa, Tanzania, Zambia, Zimbabwe          863           108       12.5%
  Kenya                                                                                                                       36             5        13.9%
                                                                                                                              29             5        17.2%
  Ghana                                                                                                                       44             1        2.3%
  Nigeria                                                                                                                     33             6        18.2%
                                                                                                                              89             2        2.2%
                                                                                                                              174           21        12.1%
                                                                                                                              29             4        13.8%
                                                                                                                              87             7        8.0%
                                                                                                                              20             0        0.0%
  South Africa                                                                                                                423            9        2.1%
                                                                                                                              106           10        9.4%
  Tanzania                                                                                                                    28             7        25.0%
  **Total (Asia)**                                                                                                         **4323**        **8**    **0.19%**
  China                                                                                                                       56             0        0.0%
  India                                                                                                                       31             0        0.0%
                                                                                                                              137            1        0.7%
                                                                                                                              179            0        0.0%
  Japan                                                                                                                      2427            2        0.1%
  Korea                                                                                                                       408            1        0.2%
  Malaysia                                                                                                                    62             0        0.0%
  Singapore                                                                                                                   217            0        0.0%
  Thailand                                                                                                                    112            0        0.0%
                                                                                                                              94             0        0.0%
  Uzbekistan                                                                                                                  67             4        6.0%
  Vietnam                                                                                                                     533            0        0.0%
  **Total (Central and South America)**                                                                                     **538**        **3**    **0.6%**
  Latin America                                                                                                               222            2        0.9%
  Chile                                                                                                                       95             0        0.0%
  Panama                                                                                                                      103            1        1.0%
  Trinidad & Tobago                                                                                                           65             0        0.0%
  Venezuela                                                                                                                   53             0        0.0%
  **Total (Eastern Mediterranean)**                                                                                         **644**        **5**    **0.8%**
  Saudi Arabia                                                                                                                34             0        0.0%
                                                                                                                              37             0        0.0%
  Israel                                                                                                                      316            0        0.0%
                                                                                                                              148            0        0.0%
  Jordan                                                                                                                      109            5        4.6%
  **Total (Europe)**                                                                                                       **2588**        **3**    **0.1%**
  Austria                                                                                                                     111            0        0.0%
  Germany                                                                                                                    1189            0        0.0%
  Ireland                                                                                                                     256            0        0.0%
                                                                                                                              24             0        0.0%
  Russia                                                                                                                      280            0        0.0%
  Spain                                                                                                                       151            1        0.7%
  Turkey                                                                                                                      105            1        1.0%
                                                                                                                              179            0        0.0%
  UK/Ireland                                                                                                                  261            1        0.4%
                                                                                                                              32             0        0.0%
  **Total (No. America)**                                                                                                  **3860**       **16**    **0.4%**
  US                                                                                                                          188            0        0.0%
                                                                                                                              183            2        1.1%
                                                                                                                             3463           14        0.4%
                                                                                                                              26             0        0.0%
  **Total (Oceania)**                                                                                                      **2738**        **1**    **0.0%**
  Australia                                                                                                                   51             0        0.0%
                                                                                                                              197            0        0.0%
                                                                                                                              147            0        0.0%
                                                                                                                             1794            1        0.1%
  New Zealand                                                                                                                 189            0        0.0%
                                                                                                                              277            0        0.0%
                                                                                                                              83             0        0.0%

Discussion {#s4}
==========

A key issue for rotavirus immunization programs in the postlicensure era is the need for safety monitoring with regard to intussusception [@pone.0068482-Bines2], [@pone.0068482-Patel1], [@pone.0068482-Tate2]. Our review of the intussusception literature from the past decade provides pertinent information that should facilitate implementation of intussusception surveillance for monitoring the postlicensure safety of rotavirus vaccines.

First, we demonstrate that natural intussusception is a very rare condition in most regions of the world, particularly among infants \<3--4 months of age when the first dose of rotavirus vaccine is typically administered. Because any potential risk with rotavirus vaccines is greatest after the first dose of vaccine which is typically recommended to be administered at 6--15 weeks of age, [@pone.0068482-Patel1] the lower rates of intussusception in this age group suggests that timely administration of vaccine would minimize the attributable risk of vaccine [@pone.0068482-Patel4]. That is, the higher rates of intussusception among infants older than 3--4 months indicates that any vaccine associated risk of intussusception could lead to more cases of intussusception associated with vaccine in settings where delays in vaccination are common. If vaccine is linked to a potential risk of intussusception, age stratified data on intussusception are necessary for interpreting these estimates of vaccine-associated risk and calculating the number of cases that are potentially attributable to vaccine after the implementation of a vaccine program [@pone.0068482-Patel4]. The age-stratified data in this review will be a valuable resource for conducting benefit risk analyses, should a rotavirus vaccine program be linked to any potential risk of intussusception.

Second, the incidence of intussusception varies substantially by region, thus highlighting the importance of the need for regional baseline data when evaluating postlicensure trends of intussusception for assessing any potential vaccine-associated risk. Risk of intussusception after the current rotavirus vaccines has also varied by region. In Mexico and Australia, postlicensure studies have identified an increased low-level risk of intussusception after the first dose of both rotavirus vaccines, ranging from 1 to 2 cases of intussusception per 100,000 vaccinated infants [@pone.0068482-Patel2], [@pone.0068482-Buttery1]. While an early study in the United States did not identify a risk of intussusception after RV5 [@pone.0068482-Shui1], a recent study has shown that a low level risk of intussusception is likely to exist with both vaccines [@pone.0068482-Haber1]. However, a similar level of risk was not observed in Brazil after RV1 [@pone.0068482-Patel2]. While these differences in risk might be related to a chance finding, effect modification of risk related to an environmental or genetic factor that differs between the populations cannot be excluded. In our review, we observed a wide range in the incidence of intussusception globally. The cause of natural intussusception in a majority of infants is not known and has been previously reviewed. Differences in infant diet, breastfeeding, maternal antibody levels, prevalence of enteropathogens (e.g., respiratory adenovirus, rotavirus) might all contribute to the differences in background rates of intussusception [@pone.0068482-WHO1], [@pone.0068482-Johnson1]. It remains unclear whether populations with higher background risk of intussusception also would carry a higher risk of vaccine-associated risk. However, any potential risk of intussusception associated with vaccine in populations with higher background risk would lead to higher number of excess cases that would be attributable to vaccine.

Third, the clinical management of intussusception in Africa differs markedly from other regions of the world where data exist, predominantly relying on clinical manifestations for diagnosis and surgery for treatment. The paucity of data on method of diagnosing intussusception from Eastern Mediterranean, Americas, and Oceania region limits the generalizability of this information in countries from these regions. In addition, limited published data are available on clinical management and outcome of intussusception in high mortality Asian countries but it would seem that surgical rates are likely to be higher than the lower mortality Asian countries. The differences in clinical management of intussusception in high mortality settings compared to low mortality settings emphasizes the need for augmenting surveillance practices depending on the location. For example, strengthening collaborations with surgeons to improve case-capture should be prioritized when monitoring the postlicensure safety of rotavirus vaccines in Africa. As rotavirus vaccines are more broadly introduced into immunization programs in Africa and Asia, these current data on the epidemiology and clinical management of intussusception should facilitate the future implementation of intussusception surveillance and inform benefit risk calculations for defining policy and decision making.

Studies assess the role of wild-type rotavirus infection as a cause of intussusception have led to conflicting findings with several studies suggesting that a significant association is unlikely [@pone.0068482-WHO1]. The absence of any marked seasonal patterns in intussusception, particularly in settings of Europe, Oceania, and Central and South America where rotavirus disease is quite seasonal supports the contention that rotavirus is unlikely to be a prominent etiologic cause of natural intussusception. This has some implications for postlicensure monitoring because attempts have previously been made to assess whether rotavirus vaccination would have a protective effect against intussusception vis-à-vis protecting against wild-type rotavirus infection. Establishing whether vaccine confers protection against intussusception might be challenging if only a small etiologic fraction of naturally occurring intussusception is related to wild-type rotavirus infection [@pone.0068482-Patel1], [@pone.0068482-Simonsen1].

Our review provides background rates of intussusception against which rates of intussusception after the introduction of vaccine could be compared for assessing potential vaccine-associated risk. However, the paucity of background rates from most settings supports the need for relying on other analytic methods of safety monitoring after the introduction of rotavirus vaccine [@pone.0068482-Bines2]. The self-controlled case-series method has now been successfully applied in several settings for assessing a potential link between vaccine and intussusception [@pone.0068482-Patel2]. This method relies on active, hospital based surveillance of intussusception and does not require information on background rates of intussusception in the population under surveillance [@pone.0068482-Farrington1]. Our review provides important considerations when establishing surveillance for intussusception. First, in resource poor settings of Africa, specific attention should be placed on hospitals with surgery suites which are likely to manage most intussusception events. While background rates are not specifically needed for the case-series method, in settings where no background rates are available, some efforts could be made to establish population-based studies which would be necessary for determining the attributable risk of vaccine, should any increased risk be identified. Lastly, the varying incidence of intussusception during the first six months of life when rotavirus vaccines are administered strongly indicates the need for addressing confounding effects of age when determining whether a causal link exists between rotavirus vaccine and intussusception cases identified through surveillance.

Intussusception case-fatality was \<1% in all developed countries of the world. However, the marked difference in case-fatality between Asia (\<1%) and Africa (9%) was intriguing. This finding might reflect differences in healthcare infrastructure or delays in care, or perhaps might be related to a publication bias with a paucity of surveillance data in the poorest populations of Asia. Previous analyses of benefits versus risk of rotavirus vaccine have conservatively assumed intussusception case-fatality rate of 25% in Asia, which in light of this review is high and could be reconsidered for future benefit risk deliberations [@pone.0068482-Patel4]. Even if case-fatality rates were to be higher than those identified in this review, some adjustment would be prudent for obtaining valid estimates of any potential risk associated with rotavirus vaccine in Asia.

Our review must be considered with some limitations. Because intussusception is a very rare condition, a fair amount of heterogeneity in surveillance practice is likely to exist across regions. In particular, establishing incidence of intussusception is rather challenging in many settings without established national or regional electronic records and thus published rates of intussusception might be prone to over or underestimation. The availability of a standardized case definition by the Brighton Collaboration reduces case misclassification but sensitivity of the case-definition might be reduced in resource poor settings where diagnostic modalities are not available and relying on clinical judgment and surgery is required for diagnosis [@pone.0068482-Bines1]. The case-fatality from these hospital based surveillance studies in resource poor settings also certainly underestimates the true case-fatality because deaths are likely to occur out of hospital. While some 30 countries had introduced a rotavirus between 2006 and 2011, all but one of the studies included in this review [@pone.0068482-Yen1] captured data before the introduction of a rotavirus vaccine.

In summary, this review of current epidemiology and clinical management of intussusception should prove to be a valuable resource for establishing intussusception surveillance and interpreting these surveillance data from various regions of the world where rotavirus vaccines are likely to be introduced in the next several years.
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